Discovery of a novel target for renal cell carcinoma

We recently reported that monotherapy using the TGase 2 inhibitor GK921 in a xenograft tumor model abrogated RCC growth through p53 stabilization.04/22/2016
Source: Kidney Cancer Association - Category: Urology & Nephrology Source Type: news